/West%20Pharmaceutical%20Services%2C%20Inc_%20phone%20and%20site-by%20T_Schneider%20via%20Shutterstock.jpg)
Exton, Pennsylvania-based West Pharmaceutical Services, Inc. (WST) designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas and internationally. The company has a market cap of $17.7 billion and is expected to release its Q1 2026 earnings soon.
Ahead of the event, analysts expect the company’s EPS to be $1.68 on a diluted basis, up 15.9% from $1.45 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of its last four quarters.